Page last updated: 2024-11-06

phentolamine and Hyperparathyroidism

phentolamine has been researched along with Hyperparathyroidism in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Labhart, A1
Fischer, J1
Müller, J1
Ziegler, W1

Other Studies

1 other study available for phentolamine and Hyperparathyroidism

ArticleYear
[Endocrinologic diagnosis of adrenal gland and parathyroid diseases].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1969, Volume: 40, Issue:7

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Insufficiency; Adrenocortical Hyperfunction

1969